Robert Joseph Stratta, MD
Robert Joseph Stratta, M.D., Professor of Surgery, Department of General Surgery, Associate Professor, Institute for Regenerative Medicine
After earning his B.S. degree at the University of Notre Dame, Robert Stratta. received his M.D. degree from the University of Chicago-Pritzker School of Medicine and trained in General Surgery at the University of Utah. He then completed a transplant clinical and research fellowship at the University of Wisconsin-Madison. He became Professor of Surgery and the Director of Pancreas Transplantation at the University of Nebraska Medical Center and Clarkson Hospital where he developed one of the largest and most successful pancreas transplant programs in the world. In 1997, he joined the transplant team as Professor of Surgery at the University of Tennessee, Memphis. Their pancreas transplant program was one of the seven largest pancreas transplant centers in the world. In October 2001, Dr. Stratta became Professor of Surgery and Director of Transplantation at WFBMC. Their Abdominal Organ Transplant program is one of the 40 most active kidney transplant and 10 most active pancreas transplant centers in the country. He has been a member of 25 medical societies, three editorial boards and has lectured worldwide on pancreas transplantation and has been selected as one of the Best Doctors in America since 1993.
SYNOPSIS OF AREA OF INTEREST: Main areas of research interest include all clinical aspects of kidney and pancreas transplantation, transplant options for the diabetic patient, new immunosuppressive drug regimens, prophylaxis and treatment of opportunistic infections, organ donation and allocation, quality of life studies in transplantation, and economic aspects of transplantation. In addition, new areas of interest include the use of expanded criteria donors, organ preservation and delayed graft function, the impact of the metabolic syndrome pre and post-transplant, and transplantation of high-risk patients (elderly, African American, highly sensitized, or retransplant candidates).
DETAILED AREA OF INTEREST: Dr. Statta's areas of research interest include kidney and pancreas transplantation, immunosuppressive strategies, opportunistic infections, organ donation and allocation, quality of life, and economic aspects of transplantation. As short-term results have consistently improved in transplantation, a paradigm shift has occurred and clinical transplantation research is now focused on long-term outcomes such as organ durability and function, composite endpoints, quality of life, economic aspects, chronic effects of immunosuppression (cardiovascular, malignancy, infectious, metabolic aspects), decreasing chronic allograft failure (both immunological and non-immunological causes), and strategies of prevention. The long-term effects of pancreas (or islet) transplantation on the secondary complications of diabetes remain a pivotal area of interest and research. In general, the emphasis has shifted away from short-term immunological and surgical outcomes to long-term quality aspects coupled with expanded donor and recipient selection criteria. The critical shortage of donor organs remains an overwhelming crisis in organ transplantation. Consequently, optimizing the current supply and actively investigating new sources or organs through regenerative medicine techniques represents a key feature of our academic and clinical pursuits.